Tokyo

London

New York

Register

Sign In

EUR/USD

1.0782

-0.0009

-0.08%

GBP/USD

1.2518

0.0044

0.35%

USD/JPY

111.00

-0.3725

-0.33%

USD/CHF

0.9932

0.0010

0.10%

EUR/GBP

0.8613

-0.0038

-0.44%

USD/CAD

1.3352

0.0019

0.15%

NZD/USD

0.7033

-0.0006

-0.09%

EUR/JPY

119.68

-0.4990

-0.42%

EUR/CHF

1.0709

0.0003

0.03%

Nektar Therapeutics

NASDAQ: NKTRHealthcare / Biotechnology / USA
22.53-0.36-1.57%Vol 2 753 5121Y Perf 78.89%
Mar 23rd, 2017 16:00
BID22.40 ASK23.29
Open22.86 Previous Close22.89
Pre-Market23.25 After-Trading22.50
 0.36 1.57%  -0.03 -0.13%
Target Price
20.17 
Analyst Rating
Strong Buy 1.00
Potencial %
-10.47 
Finscreener Ranking
—    35.67
Insiders Trans % 3/6/12M
-100/-93/-96 
Value Ranking
—    33.00
Insiders Value % 3/6/12M
-100/-96/-97 
Growth Ranking
    24.62
Insiders Shares Cnt. % 3/6/12M
-100/-96/-97 
Income Ranking
—    -
Market Cap (mil)3 521 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
92.98 
Earnings Date
2nd May 2017

Today's Price Range

22.3623.25

 

52wk Range

11.4123.37

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Neutral
Performance
1 Month
-4.89%
3 Months
-6.49%
6 Months
-19.99%
1 Year
78.89%
3 Years
8.91%
5 Years
102.12%
Last Quotes
Name / TickerPriceChg.Chg.%
NKTR22.53-0.3600-1.57
AAPL140.92-0.5000-0.35
GOOG817.58-12.0100-1.45
MSFT64.87-0.1600-0.25
XOM81.860.10000.12
WFC55.25-0.0800-0.14
JNJ125.90-0.3600-0.29
FB139.53-0.0600-0.04
GE29.620.09000.30
JPM87.39-0.1400-0.16
...

TickerPriceChg.%52 Week High
PVH98.558.48115.40
TRIP42.522.7171.69
COG22.852.7026.74
NKE55.372.6962.64
AAL41.412.6350.64
SWN7.542.4515.59
HBAN13.021.8814.74
CHK5.091.808.20
KORS37.231.7858.63
SLG107.561.75120.63
DD80.561.7481.86
WDC76.191.6881.67
DOW63.831.6664.73
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.60
Current Ratio 5.90
Long Term Debt to Total Capital 0.74
Total Debt to Equity 2.82
Interest Coverage -2.60
Leverage Ratio -101.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin80.90
EBIT Margin-73.00
EBITDA Margin-63.90
Pre-tax Profit Margin-94.60
Profit Margin-92.80
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 27.06
PS Ratios 14.41
Price to Cash Flow 22.00
Price to Free Cash Flow -19.30
Cash Flow Per Share -0.84
Price to Tangible Book205.13
Book Value per Share0.57
Enterprise Value (in ths.)2 243 870
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-435.78
ROE last 12 Months -324.73
Return on Assets (5Y Avg) -23.32
ROA last 12 Months -28.76
Return on Capital (5Y Avg) -
ROC last 12 Months -16.45
Return on invested Capital Q -12.62
Return on invested Capital Y-38.51
Assets Turnover0.10
Receivables Turnover7.30
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)165 438
Revenue per Share 1.08
Revenue Growth 3 Years 4.66
Revenue Growth 5 Years 24.35
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2016-0.26-0.28-7.69
Q03 2016-0.34-0.325.88
Q02 2016-0.32-0.36-12.50
Q01 2016-0.20-0.1430.00
Q04 2015-0.44-0.409.09
Q03 2015-0.30-0.0680.00
Q02 2015-0.27-0.40-48.15
Q01 2015-0.410.25160.98
Earnings Per EndEstimateRevision %Trend
3/2017 QR-0.40-90.48Negative
6/2017 QR-0.27-68.75Negative
12/2017 FY-1.27-45.98Negative
12/2018 FY-0.93-50.00Negative
Next Report Date2nd May 2017
Estimated EPS Next Report-0.40
Estimates Count6
EPS Growth Next 5 Years %0.00
Volume Overview
Volume2 753 512
Shares Outstanding (in ths.)153 830
Trades Count12 042
Dollar Volume48 935 920
Avg. Volume1 772 911
Avg. Weekly Volume6 880 448
Avg. Monthly Volume3 004 517
Avg. Quarterly Volume1 709 551

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7
7
8
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

Plus500
x